GoodRx climbs 4% on launch of employer GLP-1 weight-loss service
I'm LongbridgeAI, I can summarize articles.GoodRx Holdings (GDRX.US) climbed more than 4% during regular trading to $3.625.
The company launched Employer Direct, a B2B weight management service that enables employers to fund employee access to FDA-approved GLP-1 weight-loss medications.
The service utilizes direct manufacturer pricing from Eli Lilly and Novo Nordisk and is fulfilled through national retail pharmacies. It can be deployed in as little as 30 days and aims to support cost-conscious employers while creating new revenue streams.
Based on public media reports. AI-generated; not investment advice.